Important safety note Like GLP-1 receptor agonists, CagriSema is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
This property allows BPC 157 to be absorbed and used in lab tests
Common GLP-1 medications available in the UK include: GLP-1 receptor agonists: Semaglutide (Ozempic for diabetes, Wegovy for weight management) Liraglutide (Victoza for diabetes, Saxenda for weight management) Dulaglutide (Trulicity for diabetes) Dual GIP/GLP-1 receptor agonist: Tirzepatide (Mounjaro for diabetes, Zepbound for weight management) These medications are administered via subcutaneous injection, typically weekly or daily depending on the specific formulation
In NEOVA formulations, AHK-Cu is used exclusively in the Tricomin clinical hair care system
However, patients must weigh this against the ongoing financial burden and ensure they choose providers regulated by the Care Quality Commission (CQC) with prescribers registered with the appropriate professional body (GMC, NMC or GPhC)
J.MorrisonS